Neuroendocrine prostate cancer treated with multimodal examination and therapy: A case report

Neuroendocrine prostate cancer (NEPC) is rare, with short overall survival, and no established standard therapy. Therefore, the management of NEPC is often challenging. We report a case of a 63-year-old male diagnosed with NEPC and treated with multimodal examinations and therapies. Chemotherapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Midori, Kira, Satoru, Kamiyama, Manabu, Ihara, Tatsuya, Sato, Takeshi, Mitsui, Takahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284398/
https://www.ncbi.nlm.nih.gov/pubmed/35846514
http://dx.doi.org/10.1016/j.eucr.2022.102158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284398/
https://www.ncbi.nlm.nih.gov/pubmed/35846514
http://dx.doi.org/10.1016/j.eucr.2022.102158

Ejemplares similares